Moreover, we uncovered that overexpression of METTL3 partially reversed celastrol-induced downregulation of Claspin and Bcl-2, which provided the causative link between RNA m6A modification and the expression of Claspin and Bcl-2 induced by celastrol treatment in pancreatic cancer cells. Here, CLSPN is linked to familial pancreatic carcinoma.